+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Personalized medicine, pharmacogenomics, and companion diagnostics. Current and future applications of molecular diagnostics will influence these emerging fields



Personalized medicine, pharmacogenomics, and companion diagnostics. Current and future applications of molecular diagnostics will influence these emerging fields



Mlo: Medical Laboratory Observer 47(2): 22-23




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 058535812

Download citation: RISBibTeXText

PMID: 26268039


Related references

Current Trends in Personalized Medicine and Companion Diagnostics: A Summary From the DIA Meeting on Personalized Medicine and Companion Diagnostics. Therapeutic Innovation and Regulatory Science 49(4): 530-543, 2015

Molecular Pathology and Personalized Medicine: The Dawn of a New Era in Companion Diagnostics-Practical Considerations about Companion Diagnostics for Non-Small-Cell-Lung-Cancer. Journal of Personalized Medicine 6(1):, 2016

The current issues on development and clinical use of companion diagnostics and prospects of personalized medicine for the future. Yakugaku Zasshi 134(4): 491-498, 2014

Companion diagnostics: an emerging component in personalized medicine. Mlo: Medical Laboratory Observer 46(2): 10-11, 2014

Diagnostics and personalized medicine: observations from the World Companion Diagnostics Summit. Pharmacogenomics 12(4): 465-470, 2011

Molecular profiling and companion diagnostics: where is personalized medicine in cancer heading?. Personalized Medicine 11(8): 761-771, 2014

The emerging role of the molecular diagnostics laboratory in breast cancer personalized medicine. American Journal of Pathology 183(4): 1075-1083, 2013

Companion diagnostics: the key to personalized medicine. Expert Review of Molecular Diagnostics 15(2): 153-156, 2015

Reimbursement and coverage challenges associated with bringing emerging molecular diagnostics into the personalized medicine paradigm. Personalized Medicine 3(3): 345-348, 2006

Personalized Medicine Progress in regulating companion diagnostics. 2013

Companion diagnostics at the intersection of personalized medicine and healthcare delivery. Biomarkers in Medicine 9(1): 1-3, 2015

Companion diagnostics in the era of personalized medicine--chairmen's introductory remarks. Rinsho Byori. Japanese Journal of Clinical Pathology 62(4): 378-380, 2014

Meeting the technical challenges of personalized medicine and companion diagnostics. Mlo: Medical Laboratory Observer 44(1): 16 18 20 Passim, 2012

Promotion of Personalized Medicine by Appropriate Utilization of Tumor Markers and Companion Diagnostics. Rinsho Byori. Japanese Journal of Clinical Pathology 65(3): 314-316, 2017

Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan. Breast Cancer 23(1): 19-23, 2016